for the Period Ended 31 March 2024
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Debtors: | 3 |
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: | 4 |
(
|
(
|
Total net assets (liabilities): |
|
|
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2024
Basis of measurement and preparation
Turnover policy
Other accounting policies
for the Period Ended 31 March 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 March 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Other debtors |
|
|
Total |
|
|
for the Period Ended 31 March 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Other creditors |
|
|
Total |
|
|
for the Period Ended 31 March 2024
The Federation of Family Practices North Belfast C.I.C. has now completed their ninth period of accounts. They have obtained area wide coverage of the support of practices within the North Belfast Area. They have received funding from SPPG. Support of the practices enables the Federation to have a united voice in pushing forward schemes and to obtain further funding which improve training and education of our staff that ultimately will be for the benefit of our patients in the community. SPPG funding has been received for delivery of pharmacy services in general practice. The project fundamentally benefits patient care in the community.
No consultation with stakeholders
The accounts detail directors’ remuneration in the year of £33,590. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
14 November 2024
And signed on behalf of the board by:
Name: Dr Carla Devlin
Status: Director